CAROLINE CLIFTON: Open Payments
NPI 1861166977 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,430 in 36 payments from 13 companies in 2025. Trend: 2023 $23 · 2024 $107 · 2025 $1,430
Food & beverage: $1,430
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $600 |
| PFIZER INC. | 11 | $289 |
| Alexion Pharmaceuticals, Inc. | 5 | $106 |
| Ferring Pharmaceuticals Inc. | 3 | $105 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $56 |
| CSL Behring | 2 | $47 |
| Melinta Therapeutics, LLC | 2 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
Products named: Rapiblyk, VYNDAQEL, ULTOMIRIS, REBYOTA, JOURNAVX, XIFAXAN, LifeVest, Kcentra.
Industry payments across TX — which companies pay providers there.
